SkinBioTherapeutics shortlisted for Best Technology at European Mediscience Awards 2019

SkinBioTherapeutics shortlisted for Best Technology at European Mediscience Awards 2019

Manchester, UK - 16 May 2019 - SkinBioTherapeutics plc (AIM: SBTX or the "Company"), a life sciences company focused on skin health, has been shortlisted for Best Technology at the European Mediscience Awards 2019....

16th May, 2019 Read More

Director Appointment

Director Appointment

Manchester, UK - 18 April 2019 - SkinBioTherapeutics plc (AIM: SBTX or the "Company"), a life sciences company focused on skin health, announces the appointment of Stuart John Ashman to the Board as a Director with effect from 18 April 2019. As previously stated in the Company's announceme...

18th April, 2019 Read More

Director Dealing

Director Dealing

Manchester, UK - 16 April 2019 - SkinBioTherapeutics plc (AIM: SBTX - "SkinBioTherapeutics" or the "Company"), a life science company focused on skin health, announces it was notified on 15 April 2019, that Dr Cathy Prescott, a Non-Executive Director of the Company, acquired 56,1...

16th April, 2019 Read More

SkinBiotix® shows efficacy in first human study

SkinBiotix® shows efficacy in first human study

Manchester, UK - 8 April 2019 - SkinBioTherapeutics plc (AIM: SBTX - "SkinBioTherapeutics" or the "Company"), a life science company focused on skin health, provides the results of its first human study....

8th April, 2019 Read More

CEO Designate Appointment

CEO Designate Appointment

Manchester, UK - 29 March 2019 - SkinBioTherapeutics plc (AIM: SBTX or the "Company"), a life sciences company focused on skin health, announces the appointment of Stuart Ashman as an Executive Director of the Company, subject to the completion of regulatory due diligence checks....

29th March, 2019 Read More

Issue of Equity and Related Party Transaction

Issue of Equity and Related Party Transaction

SkinBioTherapeutics plc (AIM: SBTX) ("SkinBioTherapeutics" or the "Company"), a life sciences company focused on skin health, announces that it has raised a total of £1,500,000 via a placing of 9,375,000 new ordinary shares ("Placing Shares") at a price of 16 penc...

18th February, 2019 Read More
investors logo